Stool Softener Tablet
NDC Package 72476-855-10
Package Information
Stool Softener (docusate sodium and sennosides) tablets is a medication used to treat occasional constipation. This formulation utilizes a tablet delivery system. Marketed by Care One (retail Business Services, Llc.), this product is identified by NDC 72476-855 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
- RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72476 - Care One (retail Business Services, Llc.)
- 72476-855 - Stool Softener
- 72476-855-10 - 1 BOTTLE, PLASTIC in 1 BOX / 100 TABLET in 1 BOTTLE, PLASTIC
- 72476-855 - Stool Softener
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72476-855-10 identifies a specific commercial package of 1 bottle, plastic in 1 box / 100 tablet in 1 bottle, plastic of Stool Softener Plus Stimulant Laxative, a human over the counter drug labeled by Care One (retail Business Services, Llc.). This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Care One (retail Business Services, Llc.) on June 30, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat occasional constipation. Some medications and conditions can make constipation more likely. Stool softeners such as docusate are often the first method used for preventing and treating this type of constipation. Docusate is often used when straining to have a bowel movement should be avoided (e.g., after a heart attack or surgery). Docusate is a stool softener. It works by increasing the amount of water the stool absorbs in the gut, making the stool softer and easier to pass.
How is this Care One (retail Business Services, Llc.) product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72476085510. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.